FDA Sets Review Period for ZURZUVAE Drug Patent Extension
Published Date: 1/6/2026
Notice
Summary
The FDA has set the official review period for the drug ZURZUVAE, which helps the company extend its patent protection. This means the drug maker might get extra time to keep their invention exclusive, potentially affecting when generic versions can appear. If anyone thinks the dates are wrong or wants to challenge the company’s effort during review, they have until early 2026 to speak up.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2026-00025, Gulf Fishery Management Council; Public Meeting
The Gulf Fishery Management Council is hosting a virtual meeting on January 22, 2026, to review important fish health reports and discuss fishing rules that affect Gulf fishermen and seafood lovers. This meeting helps make sure fish populations stay healthy and fishing stays fair, with no immediate cost changes announced. Anyone interested can join online and share their thoughts during the public comment time.
Next: 2026-00027, Gulf Fishery Management Council; Public Meeting
The Gulf Fishery Management Council is holding a 3-day meeting from January 26-28, 2026, to discuss important changes affecting fishing rules and data collection in the Gulf of America. Fishermen, businesses, and communities depending on Gulf fisheries should pay attention, as budget plans, reporting rules, and communication tools will be updated. You can join in person in New Orleans or tune in online—no fishing license needed to listen!